For security purposes
FOR SECURITY PURPOSES - because Internet Explorer is no longer supported by Microsoft, we suggest that you interact with our secure site through one of our supported browsers - Google Chrome, Firefox, or MS Edge. If you continue to use this website with Internet Explorer you do so at your own risk and you may encounter problems.
search
Product Information
Phase Detail
Biosep SEC-s2000
BioSep SEC-s2000 SEC/ GFC phase is well suited for biogeneric aggregate, peptide therapeutics, PEGylated peptides, PEGylated small proteins

Biosep SEC-s2000

BioSep SEC-s2000 SEC/GFC phase has an exclusion range of:

  • 1,000 - 300,000 Da (Native)
  • 200 - 75,000 Da (0.5% SDS)
  • 500 - 100,000 Da (6M GnHCl)

Particle Size
5
Recommended Use
Ideal for biogeneric aggregate applications, peptide therapeutics, small proteins, PEGylated peptides, and PEGylated small proteins.

Biosep SEC-s2000 Documents
search Search All Documents

backspace Clear Filter
Showing 1-4 of 4 results
Type unfold_moreDocument Title unfold_more
Technical NotesPEGylated Proteins by Reversed Phase HPLC (TN-1046)
Technical NotesPEGylated Proteins by GFC (TN-1048)
BrochuresBioSep GFC/SEC Brochure
BrochuresUSP Allowable Adjustments Guide
Phenomenex logo
Headquarters
411 Madrid Avenue, Torrance, CA 90501
t: (310) 212-0555 f: (310) 328-7768

OUR PRODUCTS AND SERVICES

Products

Techniques

Industries

OUR COMPANY 

About Phenomenex

Our Humanity

Our People

Blog

Danaher Life Sciences

Stay up to date on the latest from Phenomenex
Iso logo
Terms and Conditions Privacy Statement Quality Policy Terms of Use Trademarks CA Supply Chains Act CA Consumer Privacy Act Cookie Policy Cookie Settings © 2023 Phenomenex Inc. All rights reserved.